Abstract: The present invention addresses the problem of providing: a method for producing brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells from somatic cells without performing artificial gene transfer; brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells; or a composition including a combination of chemical substances that can be used for the aforementioned production method. An example of the present invention is a method for producing brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells including a step for culturing somatic cells in the presence or absence of an inhibitor or activator selected from the group consisting of an ALK5 inhibitor, an ALK6 inhibitor, an AMPK inhibitor, a cAMP activator, an ALK2 inhibitor, an ALK3 inhibitor, a GSK3 inhibitor, and an Erk inhibitor.

Abstract: There is provided a method for recycling a catalyst that exhibits a high denitration efficiency at a relatively low temperature and does not cause oxidation of SO2 in a selective catalytic reduction reaction that uses ammonia as a reducing agent. A method for recycling a denitration catalyst includes a step of spraying an aqueous solution with a pH of 7 or more onto a used denitration catalyst while the denitration catalyst is set in a denitration device to remove a surface of the denitration catalyst. The denitration catalyst contains 43 wt % or more of vanadium pentoxide and has a BET specific surface area of 30 m2/g or more. The denitration catalyst after recycling is used for denitration at 200° C. or lower.

Abstract: There is provided a method for recycling a catalyst that exhibits a high denitration efficiency at a relatively low temperature and does not cause oxidation of SO2 in a selective catalytic reduction reaction that uses ammonia as a reducing agent. A method for recycling a denitration catalyst includes a step of removing a used denitration catalyst from a denitration device and then coating the used denitration catalyst with a catalyst component. The catalyst component contains 43 wt % or more of vanadium pentoxide and has a BET specific surface area of 30 m2/g or more, and the denitration catalyst after recycling is used for denitration at 200° C. or lower.

Abstract: The present invention addresses the problem of providing: a method for producing brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells from somatic cells without performing artificial gene transfer; brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells; or a composition including a combination of chemical substances that can be used for the aforementioned production method. An example of the present invention is a method for producing brown adipocytes, osteoblasts, cartilage cells, neural cells, or cardiac cells including a step for culturing somatic cells in the presence or absence of an inhibitor or activator selected from the group consisting of an ALK5 inhibitor, an ALK6 inhibitor, an AMPK inhibitor, a cAMP activator, an ALK2 inhibitor, an ALK3 inhibitor, a GSK3 inhibitor, and an Erk inhibitor.

Abstract: A method for regenerating an NOx removal catalyst, which includes connecting an upstream fixing member (10) to one end of a member to be ground, and connecting a downstream fixing member (20) to the other end; connecting a mixing part (40) for mixing an abrasive with a gas to an upstream portion of the upstream fixing member, and disposing a screen member in the expanded part, and connecting a classification part (70) and a dust-collecting part (80) to the downstream fixing member; and transferring the abrasive which has been mixed with the gas from the mixing part to the upstream fixing member, reducing the flow rate of the mixture in the expanded part, subsequently, causing the mixture to pass through the through-hole of the NOx removal catalyst and the downstream fixing member, and then collecting dust by means of the dust-collecting part via the classification part.

Abstract: There is provided a catalyst that exhibits a high denitration efficiency at a relatively low temperature and does not cause oxidation of SO2 in a selective catalytic reduction reaction that uses ammonia as a reducing agent. A denitration catalyst molded in a block shape contains 43 wt % or more of vanadium pentoxide. The denitration catalyst has a BET specific surface area of 30 m2/g or more and is used for denitration at 200° C. or lower.

Abstract: There is provided a method for recycling a catalyst that exhibits a high denitration efficiency at a relatively low temperature and does not cause oxidation of SO2 in a selective catalytic reduction reaction that uses ammonia as a reducing agent. A method for recycling a denitration catalyst includes a step of removing a used denitration catalyst from a denitration device and then coating the used denitration catalyst with a catalyst component. The catalyst component contains 43 wt % or more of vanadium pentoxide and has a BET specific surface area of 30 m2/g or more, and the denitration catalyst after recycling is used for denitration at 200° C. or lower.

Abstract: There is provided a method for recycling a catalyst that exhibits a high denitration efficiency at a relatively low temperature and does not cause oxidation of SO2 in a selective catalytic reduction reaction that uses ammonia as a reducing agent. A method for recycling a denitration catalyst includes a step of spraying an aqueous solution with a pH of 7 or more onto a used denitration catalyst while the denitration catalyst is set in a denitration device to remove a surface of the denitration catalyst. The denitration catalyst contains 43 wt % or more of vanadium pentoxide and has a BET specific surface area of 30 m2/g or more. The denitration catalyst after recycling is used for denitration at 200° C. or lower.

Abstract: A method for regenerating an NOx removal catalyst, which includes connecting an upstream fixing member (10) to one end of a member to be ground, and connecting a downstream fixing member (20) to the other end; connecting a mixing part (40) for mixing an abrasive with a gas to an upstream portion of the upstream fixing member, and disposing a screen member in the expanded part, and connecting a classification part (70) and a dust-collecting part (80) to the downstream fixing member; and transferring the abrasive which has been mixed with the gas from the mixing part to the upstream fixing member, reducing the flow rate of the mixture in the expanded part, subsequently, causing the mixture to pass through the through-hole of the NOx removal catalyst and the downstream fixing member, and then collecting dust by means of the dust-collecting part via the classification part.

Abstract: Provided is an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.

Abstract: There is provided an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis or the like. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.

Abstract: There is provided an agent having at least one of an improving effect on vascular endothelial functions and an inhibitory effect on vascular intimal thickening, as well as a prophylactic of arteriosclerosis, which have excellent safety, improve functions associated with the vascular endothelium, have effects of preventing various diseases associated with vascular endothelial functions and of inhibiting vascular intimal thickening, and may be expected to provide prophylactic effect on arteriosclerosis or the like. The agents of the present invention contain, as an active component: (a) Xaa-Pro-Pro, (b) a hydrolysate of animal milk casein containing Xaa-Pro-Pro, or a concentrate thereof, or (c) a fermentation product containing Ile-Pro-Pro and/or Val-Pro-Pro obtained by fermenting a starting material containing milk protein with a bacterial strain of the species Lactobacillus helveticus.

Abstract: A method that adjusts an optical apparatus that guides a radiation from a first surface to a second surface includes a number of steps, for example. A first step measures an aberration of the optical apparatus having a plurality of optical elements and at least one correction element. A second step calculates, based on a measurement result of the first step, a surface shape that the correction element should have, the aberration of the optical apparatus being a predetermined value when the correction element has the surface shape that the correction element should have. A third step removes the correction element from the optical apparatus and machines the correction element so that the surface shape of the correction element coincides with the surface shape calculated in the second step. A fourth step returns the correction element machined in the third step into the optical apparatus.

Abstract: Provided is a method of evaluation of antioxidation level through determination of in-vivo redox balance. The redox balance is represented by a formula: redox balance=(antioxidation index after administration/oxidation index after administration)/(antioxidation index before administration/oxidation index before administration). The antioxidation index is obtained by indexing the antioxidation level that is obtained through quantitative determination of the signal intensity attenuation with serum addition thereto of the DMPO-OOL radical formed through trapping of a butylhydroperoxide radical by 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) by the use of a magnetic spin resonator followed by analysis of the data for 10-grade frequency distribution of from 1 to 10, and the oxidation index is obtained by indexing the oxidation level that is obtained through quantitative determination of 8-hydroxydeoxyguanosine (8-OHdG) in urine followed by analysis of the data for 10-grade frequency distribution of from 1 to 10.

Abstract: This invention relates to an adjusting method for correcting the random component of distortion of a projection optical apparatus without performing complicated assembly and adjustment. This adjusting method has the first step of measuring the residual distortion component of a projection optical system having a predetermined target member in its optical path, the second step of calculating, based on the measurement result of the first step, the surface shape of the target member to cancel the residual distortion component, the third step of removing the target member from the projection optical system and machining the target member so as to have the surface shape calculated in the second step, and the fourth step of inserting the target member machined in the third step into the optical path of the projection optical system.

Abstract: An agent for preventing and curing the hindrance of ischemic reperfusiton is disclosed which has as an active component thereof a chromanol glycoside represented by the following general formula: [wherein R1, R2, R3, and R4 independently denote a hydrogen atom or a lower alkyl group, R5 denotes a hydrogen atom, a lower alkyl group, or a lower acyl group, X denotes a monosaccharide residue or an oligosaccharide residue which may have a lower alkyl group or a lower acyl group substituted for the hydrogen atom of the hydroxyl group of the saccharide residue, n denotes an integer of 0-6, and m denotes an integer of 1-6]. The agent, even in a small dosage, acts safely and effectively on the affected part and allows the hindrances of ischemic reperfusion induced in heart, stomach, small intestine, liver, spleen, kidney, brain, and skin, and the hindrance induced during the transplantation of an internal organ to be prevented and cured.

Abstract: An agent for preventing and curing the hindrance of ischemic reperfusiton is disclosed which has as an active component thereof a chromanol glycoside represented by the following general formula: 1

Abstract: A signal prediction device and camera including a signal prediction device are provided in which the signal prediction device includes a signal detection part for detecting a signal series, a prediction coefficient calculation part for calculating prediction coefficients using the detected signal series, and a prediction calculation part for performing operations on the prediction coefficients and an updated signal series to predict future signals, wherein the updated signal series includes at least one future signal value for which a prediction operation has been previously performed from a signal series detected by the signal detection part and the prediction coefficients as the current signals.

Abstract: This invention relates to an adjusting method for correcting the random component of distortion of a projection optical apparatus without performing complicated assembly and adjustment. This adjusting method has the first step of measuring the residual distortion component of a projection optical system having a predetermined target member in its optical path, the second step of calculating, based on the measurement result of the first step, the surface shape of the target member to cancel the residual distortion component, the third step of removing the target member from the projection optical system and machining the target member so as to have the surface shape calculated in the second step, and the fourth step of inserting the target member machined in the third step into the optical path of the projection optical system.

Abstract: A method adjusts optical performance of a projection optical system for projecting an image of a first object onto a second object. An optical member is provided having a predetermined optical surface, at a predetermined position of the projection optical system. Measurement is made of an aberration having a random aberration component in the projection optical system including the optical member at the predetermined position. A correction shape is obtained to correct the random aberration component. The correction shape is then formed on a correction optical member, and that correction optical member is arranged at the predetermined position of the projection optical system.